Trial Profile
A SURVEY TO STUDY THE CORRELATION BETWEEN THE SERUM LEVELS OF BONE TURNOVER MARKERS AND THE CLINICAL PICTURE IN PATIENTS WITH BREAST CANCER AND BONE METASTASES RECEIVING IBRADONIC ACID TREATMENT
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Sep 2015
Price :
$35
*
At a glance
- Drugs Ibandronic acid (Primary)
- Indications Breast cancer; Male breast cancer
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Roche
- 22 Sep 2015 New trial record